ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents

Deepak L. Bhatt; James Scheiman; Neena S. Abraham; Elliott M. Antman; Francis K.L. Chan; Curt D. Furberg; David A. Johnson; Kenneth W. Mahaffey; Eamonn M. Quigley; Robert A. Harrington; Eric R. Bates; Charles R. Bridges; Mark J. Eisenberg; Victor A. Ferrari; Mark A. Hlatky; Sanjay Kaul; Jonathan R. Lindner; David J. Moliterno; Debabrata Mukherjee; Richard S. Schofield; Robert S. Rosenson; James H. Stein; Howard H. Weitz; Deborah J. Wesley

doi:10.1161/CIRCULATIONAHA.108.191087

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents

Deepak L. Bhatt, James Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K.L. Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M. Quigley, Robert A. Harrington, Eric R. Bates, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, Mark A. Hlatky, Sanjay Kaul, Jonathan R. Lindner, David J. Moliterno, Debabrata Mukherjee, Richard S. SchofieldRobert S. Rosenson, James H. Stein, Howard H. Weitz, Deborah J. Wesley

Research output: Contribution to journal › Article › peer-review

441 Scopus citations

Abstract

In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.

Original language	English (US)
Pages (from-to)	1894-1909
Number of pages	16
Journal	Circulation
Volume	118
Issue number	18
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.108.191087
State	Published - Oct 28 2008

Keywords

AHA Scientific Statements
Antiplatelet therapy
Aspirin
Gastroduodenal ulcer
Gastrointestinal bleeding
Gastrointestinal risk
NSAID
Stents
Thrombosis

ASJC Scopus subject areas

Physiology (medical)
Cardiology and Cardiovascular Medicine

Access to Document

10.1161/CIRCULATIONAHA.108.191087

Fingerprint

Dive into the research topics of 'ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents'. Together they form a unique fingerprint.

Cite this

Bhatt, D. L., Scheiman, J., Abraham, N. S., Antman, E. M., Chan, F. K. L., Furberg, C. D., Johnson, D. A., Mahaffey, K. W., Quigley, E. M., Harrington, R. A., Bates, E. R., Bridges, C. R., Eisenberg, M. J., Ferrari, V. A., Hlatky, M. A., Kaul, S., Lindner, J. R., Moliterno, D. J., Mukherjee, D., ... Wesley, D. J. (2008). ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. Circulation, 118(18), 1894-1909. https://doi.org/10.1161/CIRCULATIONAHA.108.191087

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. / Bhatt, Deepak L.; Scheiman, James; Abraham, Neena S. et al.
In: Circulation, Vol. 118, No. 18, 28.10.2008, p. 1894-1909.

Research output: Contribution to journal › Article › peer-review

Bhatt, DL, Scheiman, J, Abraham, NS, Antman, EM, Chan, FKL, Furberg, CD, Johnson, DA, Mahaffey, KW, Quigley, EM, Harrington, RA, Bates, ER, Bridges, CR, Eisenberg, MJ, Ferrari, VA, Hlatky, MA, Kaul, S, Lindner, JR, Moliterno, DJ, Mukherjee, D, Schofield, RS, Rosenson, RS, Stein, JH, Weitz, HH & Wesley, DJ 2008, 'ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents', Circulation, vol. 118, no. 18, pp. 1894-1909. https://doi.org/10.1161/CIRCULATIONAHA.108.191087

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FKL, Furberg CD et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. Circulation. 2008 Oct 28;118(18):1894-1909. doi: 10.1161/CIRCULATIONAHA.108.191087

@article{9e75a3085a8d432990df2f34aa62ac3f,

title = "ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents",

abstract = "In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.",

keywords = "AHA Scientific Statements, Antiplatelet therapy, Aspirin, Gastroduodenal ulcer, Gastrointestinal bleeding, Gastrointestinal risk, NSAID, Stents, Thrombosis",

author = "Bhatt, {Deepak L.} and James Scheiman and Abraham, {Neena S.} and Antman, {Elliott M.} and Chan, {Francis K.L.} and Furberg, {Curt D.} and Johnson, {David A.} and Mahaffey, {Kenneth W.} and Quigley, {Eamonn M.} and Harrington, {Robert A.} and Bates, {Eric R.} and Bridges, {Charles R.} and Eisenberg, {Mark J.} and Ferrari, {Victor A.} and Hlatky, {Mark A.} and Sanjay Kaul and Lindner, {Jonathan R.} and Moliterno, {David J.} and Debabrata Mukherjee and Schofield, {Richard S.} and Rosenson, {Robert S.} and Stein, {James H.} and Weitz, {Howard H.} and Wesley, {Deborah J.}",

year = "2008",

month = oct,

day = "28",

doi = "10.1161/CIRCULATIONAHA.108.191087",

language = "English (US)",

volume = "118",

pages = "1894--1909",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "18",

}

TY - JOUR

T1 - ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use

T2 - A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents

AU - Bhatt, Deepak L.

AU - Scheiman, James

AU - Abraham, Neena S.

AU - Antman, Elliott M.

AU - Chan, Francis K.L.

AU - Furberg, Curt D.

AU - Johnson, David A.

AU - Mahaffey, Kenneth W.

AU - Quigley, Eamonn M.

AU - Harrington, Robert A.

AU - Bates, Eric R.

AU - Bridges, Charles R.

AU - Eisenberg, Mark J.

AU - Ferrari, Victor A.

AU - Hlatky, Mark A.

AU - Kaul, Sanjay

AU - Lindner, Jonathan R.

AU - Moliterno, David J.

AU - Mukherjee, Debabrata

AU - Schofield, Richard S.

AU - Rosenson, Robert S.

AU - Stein, James H.

AU - Weitz, Howard H.

AU - Wesley, Deborah J.

PY - 2008/10/28

Y1 - 2008/10/28

N2 - In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.

AB - In appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.

KW - AHA Scientific Statements

KW - Antiplatelet therapy

KW - Aspirin

KW - Gastroduodenal ulcer

KW - Gastrointestinal bleeding

KW - Gastrointestinal risk

KW - NSAID

KW - Stents

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=56749183852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749183852&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.191087

DO - 10.1161/CIRCULATIONAHA.108.191087

M3 - Article

C2 - 18836135

AN - SCOPUS:56749183852

SN - 0009-7322

VL - 118

SP - 1894

EP - 1909

JO - Circulation

JF - Circulation

IS - 18

ER -

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this